We observed a good agreement among hematologists regarding the diagnostic procedures and a widespread awareness regarding the importance of the new 2016 WHO criteria and bone marrow his-tology. On the other side, we observed a marked heterogeneity in treatment practice, regarding both the Hct threshold and the use of anti-platelet agents.

Facing erythrocytosis: Results of an international physician survey.

Rumi E;Sant'Antonio E;Cavalloni C;Trotti C;
2019-01-01

Abstract

We observed a good agreement among hematologists regarding the diagnostic procedures and a widespread awareness regarding the importance of the new 2016 WHO criteria and bone marrow his-tology. On the other side, we observed a marked heterogeneity in treatment practice, regarding both the Hct threshold and the use of anti-platelet agents.
File in questo prodotto:
Non ci sono file associati a questo prodotto.

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11571/1321873
Citazioni
  • ???jsp.display-item.citation.pmc??? 6
  • Scopus 11
  • ???jsp.display-item.citation.isi??? 11
social impact